125 related articles for article (PubMed ID: 8893045)
21. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the O-demethylation processes.
Mutlib AE; Nelson WL
Drug Metab Dispos; 1990; 18(3):309-14. PubMed ID: 1974191
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.
Fennell TR; Miller JA; Miller EC
Cancer Res; 1984 Aug; 44(8):3231-40. PubMed ID: 6744260
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of citral, an alpha,beta-unsaturated aldehyde, in male F344 rats.
Diliberto JJ; Srinivas P; Overstreet D; Usha G; Burka LT; Birnbaum LS
Drug Metab Dispos; 1990; 18(6):866-75. PubMed ID: 1981530
[TBL] [Abstract][Full Text] [Related]
24. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
25. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
Theobald DS; Staack RF; Puetz M; Maurer HH
J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
[TBL] [Abstract][Full Text] [Related]
26. Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone.
Mutlib AE; Strupczewski JT; Chesson SM
Drug Metab Dispos; 1995 Sep; 23(9):951-64. PubMed ID: 8565786
[TBL] [Abstract][Full Text] [Related]
27. Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile.
Monsarrat B; Mariel E; Cros S; Garès M; Guénard D; Guéritte-Voegelein F; Wright M
Drug Metab Dispos; 1990; 18(6):895-901. PubMed ID: 1981534
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of the antianxiety drug buspirone in human subjects.
Jajoo HK; Mayol RF; LaBudde JA; Blair IA
Drug Metab Dispos; 1989; 17(6):634-40. PubMed ID: 2575499
[TBL] [Abstract][Full Text] [Related]
29. Identification of the metabolites of roxithromycin in humans.
Zhong D; Li X; Wang A; Xu Y; Wu S
Drug Metab Dispos; 2000 May; 28(5):552-9. PubMed ID: 10772634
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
31. An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine.
Zhang H; Ma L; He K; Zhu M
J Mass Spectrom; 2008 Sep; 43(9):1191-200. PubMed ID: 18521834
[TBL] [Abstract][Full Text] [Related]
32. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of pantoprazole involving conjugation with glutathione in rats.
Zhong D; Xie Z; Chen X
J Pharm Pharmacol; 2005 Mar; 57(3):341-9. PubMed ID: 15807990
[TBL] [Abstract][Full Text] [Related]
35. Characterization of urinary metabolites of a new benzofuroquinoline derivative, 3,9-bis(N,N-dimethylcarbamoyloxy)-5 H-benzofuro[3,2-c]-quinoline-6-one (KCA-098), in dogs.
Yamada T; Yamamoto A; Fujioka M; Miyagi M; Saito N; Imai I; Otagiri M
Pharmazie; 1999 Sep; 54(9):672-7. PubMed ID: 10522271
[TBL] [Abstract][Full Text] [Related]
36. Identification of etretinate metabolites in human bile.
Vane FM; Buggé CJ; Rodriguez LC
Drug Metab Dispos; 1989; 17(3):275-9. PubMed ID: 2568908
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of 14C-thymoxamine in rat and man.
Duchene P; Bernouillet C; Bromet-Petit M; Mosser J; Feniou C; Gaudin D; Virelizier H
Xenobiotica; 1988 Aug; 18(8):919-28. PubMed ID: 2973182
[TBL] [Abstract][Full Text] [Related]
39. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of 1-(3-[3-(4-cyanobenzyl)-3H-imidazol-4-yl]-propyl)-3-(6-methoxypyridin-3-yl)-1-(2-trifluoromethylbenzyl)thiourea (YH3945), a novel anti-cancer drug, in rats using the 14C-labeled compound.
Lee J; La S; Ahn BR; Jeong TC; Kim DH
Rapid Commun Mass Spectrom; 2004; 18(17):1901-10. PubMed ID: 15329855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
